X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs GSK PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD GSK PHARMA ORCHID PHARMA LTD/
GSK PHARMA
 
P/E (TTM) x -0.7 59.2 - View Chart
P/BV x 0.5 11.6 4.6% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 ORCHID PHARMA LTD   GSK PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
GSK PHARMA
Mar-16
ORCHID PHARMA LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1943,850 5.0%   
Low Rs352,966 1.2%   
Sales per share (Unadj.) Rs276.5332.3 83.2%  
Earnings per share (Unadj.) Rs-79.244.3 -178.8%  
Cash flow per share (Unadj.) Rs-43.547.2 -92.0%  
Dividends per share (Unadj.) Rs050.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs53.9202.7 26.6%  
Shares outstanding (eoy) m70.4584.70 83.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.410.3 4.0%   
Avg P/E ratio x-1.476.9 -1.9%  
P/CF ratio (eoy) x-2.672.2 -3.7%  
Price / Book Value ratio x2.116.8 12.6%  
Dividend payout %0112.9 0.0%   
Avg Mkt Cap Rs m8,067288,643 2.8%   
No. of employees `0002.84.6 60.7%   
Total wages/salary Rs m2,5274,434 57.0%   
Avg. sales/employee Rs Th6,956.16,104.5 113.9%   
Avg. wages/employee Rs Th902.5961.6 93.9%   
Avg. net profit/employee Rs Th-1,993.0813.7 -244.9%   
INCOME DATA
Net Sales Rs m19,47728,148 69.2%  
Other income Rs m4071,218 33.4%   
Total revenues Rs m19,88429,366 67.7%   
Gross profit Rs m1,1034,774 23.1%  
Depreciation Rs m2,519248 1,015.8%   
Interest Rs m5,2270-   
Profit before tax Rs m-6,2365,744 -108.6%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m51126 1,965.4%   
Tax Rs m-1252,018 -6.2%   
Profit after tax Rs m-5,5803,752 -148.7%  
Gross profit margin %5.717.0 33.4%  
Effective tax rate %2.035.1 5.7%   
Net profit margin %-28.713.3 -214.9%  
BALANCE SHEET DATA
Current assets Rs m11,01421,462 51.3%   
Current liabilities Rs m32,06010,536 304.3%   
Net working cap to sales %-108.138.8 -278.4%  
Current ratio x0.32.0 16.9%  
Inventory Days Days9568 140.2%  
Debtors Days Days3416 204.4%  
Net fixed assets Rs m29,4404,717 624.1%   
Share capital Rs m705847 83.2%   
"Free" reserves Rs m2,04316,308 12.5%   
Net worth Rs m3,80017,171 22.1%   
Long term debt Rs m9,01816 56,361.9%   
Total assets Rs m46,51030,620 151.9%  
Interest coverage x-0.2NM-  
Debt to equity ratio x2.40 254,694.6%  
Sales to assets ratio x0.40.9 45.6%   
Return on assets %-0.812.3 -6.2%  
Return on equity %-146.921.9 -672.1%  
Return on capital %-3.733.6 -11.1%  
Exports to sales %37.90 266,551.0%   
Imports to sales %22.615.1 150.3%   
Exports (fob) Rs m7,3784 184,440.0%   
Imports (cif) Rs m4,4064,237 104.0%   
Fx inflow Rs m7,513519 1,447.6%   
Fx outflow Rs m5,6498,320 67.9%   
Net fx Rs m1,865-7,801 -23.9%   
CASH FLOW
From Operations Rs m1,6821,386 121.4%  
From Investments Rs m-9,8605,010 -196.8%  
From Financial Activity Rs m6,644-6,383 -104.1%  
Net Cashflow Rs m-1,53512 -13,008.5%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 4.6 10.2 45.1%  
FIIs % 3.3 23.8 13.9%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 15.4 359.1%  
Shareholders   84,811 102,036 83.1%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   SHASUN PHARMA  CIPLA  ASTRAZENECA PHARMA  SUVEN LIFE  STERLING BIOTECH  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS